The Synthetic-Technical Development of Oseltamivir Phosphate Tamiflu™: A Race against Time

The Synthetic-Technical Development of Oseltamivir Phosphate Tamiflu™: A Race against Time

The clinical development of the first orally available neuraminidase inhibitor prodrug oseltamivir phosphate (Tamiflu™) proceeded very fast. In order to support this program an unprecedented team effort in chemical process research, development, piloting, production and analytics took plac...

Full description

Bibliographic Details
Main Authors: Stefan Abrecht, René Trussardi, Gösta Rimmler, Thomas Oberhauser, Hans-Jürgen Mair, Martin Karpf, Rolf Fischer, Heinrich Estermann, Muriel Cordon Federspiel, Ulrich Zutter
Format: Article
Language:deu
Published: Swiss Chemical Society 2007-03-01
Series:CHIMIA
Subjects:
Analytics
Influenza neuraminidase inhibitor
Oseltamivir phosphate
Production
Synthesis
Technical development
Online Access:https://chimia.ch/chimia/article/view/4283

Internet

https://chimia.ch/chimia/article/view/4283

Similar Items